In which of the following phases of clinical trial of drugs, ethical clearance is not required ?
**Question:** In which of the following phases of clinical trial of drugs, ethical clearance is not required?
A. Preclinical trials (Phase I)
B. Post-marketing surveillance
C. Drug discovery and development (Phase 0)
D. Quality control and manufacturing (Phase IV)
**Core Concept:**
Phases of clinical trials refer to the sequential stages a drug goes through to ensure safety, efficacy, and quality before being approved for use in human patients. Ethical clearance is essential to ensure that human subjects are protected from harm and that their rights are respected throughout these trials.
**Why the Correct Answer is Right:**
Ethical clearance is not required in the phase of drug discovery and development (Phase 0). In this phase, the drug is tested in a limited number of human volunteers to evaluate drug distribution, pharmacokinetics, and safety. Ethical concerns are addressed in different phases, and Phase 0 is focused on basic scientific investigation and not human subject safety.
**Why Each Wrong Option is Incorrect:**
A. Preclinical trials (Phase I): While Phase I trials include human subjects, ethical clearance is still essential for protecting participants from potential harm and ensuring their rights are respected.
B. Post-marketing surveillance: This phase focuses on monitoring the drug's safety and efficacy after it is approved and marketed, but ethical clearance is still important to ensure continued drug safety and adherence to regulations.
C. Drug discovery and development (Phase 0): As explained above, ethical clearance is not required in Phase 0; however, it is important in other phases.
D. Quality control and manufacturing (Phase IV): Ethical clearance is necessary in this phase for protection of patients participating in monitoring the drug's safety after it is approved and marketed.
**Clinical Pearl:**
Ethical clearance is a crucial aspect of clinical trials that ensures patient safety, respect for patients' rights, and adherence to regulations. It is essential throughout the drug development process, although its requirements might vary among phases.